Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
about
Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future DirectionsRecent Advancements of Treatment for Leptomeningeal CarcinomatosisFeasibility of intraventricular administration of etoposide in patients with metastatic brain tumoursCarcinomatous Meningitis from Unknown Primary Carcinoma.Leptomeningeal metastases in the MRI era.Contrast-Enhancing Meningeal Lesions Are Associated with Longer Survival in Breast Cancer-Related Leptomeningeal Metastasis.Defining patients at risk for neoplastic meningitis: what parameters can be used to determine who should be treated?Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical noteNovel approaches to treating leptomeningeal metastases.Liposomes for brain delivery.Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature.Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.Chemotherapy-Related Neurotoxicity.Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.Pulsed Erlotinib as Sole Treatment of Leptomeningeal Carcinomatosis: Can We Avoid the Use of Intrathecal Therapy?Leptomeningeal metastasis from systemic cancer: Review and update on management.Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery.Risk of leptomeningeal carcinomatosis in patients with brain metastases treated with stereotactic radiosurgery.Complications related to the placement of an intraventricular chemotherapy device.Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.Safety of Ommaya reservoirs in children with brain tumors: a 20-year experience with 5472 intraventricular drug administrations in 98 patients.Alterations in surgical plan based on intraoperative portable head computed tomography imaging.High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs.Drug-Induced Aseptic Meningitis Associated With Intrathecal Trastuzumab.Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases
P2860
Q26741320-5A53E2BD-4C16-4E75-9AC1-641E09ED6244Q26798009-2C243018-78FA-49F1-8333-B79D581EEE8FQ28366035-088BD7E1-E254-400B-8C7D-E23DDF11201AQ30479900-943DC90C-C7AA-4CD1-B561-51E2A824046DQ33853342-89C39402-08A1-4B1D-A78C-FFF838950F95Q34096206-94458016-7140-4F6E-A4AC-C72ADC7BB629Q36107045-2825723A-B9BF-4C9A-AB23-08A7750F31D3Q36118160-94AFCAFB-1D95-4E2F-98BA-082B6DF71384Q36762275-BDBBA0EC-8F51-4137-9540-206DC85BD63DQ37923386-1EC7EEA4-E058-469D-9D3B-3E6887AA1EE8Q38078421-49EE219F-8F11-4AD0-BC7A-13544358EFA0Q38691228-D6EFC07B-B85B-4D01-B12E-0BA85F4F96B9Q38795453-F19B6593-7D38-4DDD-B7A2-3AAD0227E303Q38904676-507D19D0-3E1B-4BFA-B613-6BF8D1D3E4D5Q41164956-4798C73F-6533-4BB1-9204-619306EAECB4Q44434925-E3D9F218-A667-4991-9189-4C7A57C5B6FBQ47428678-64580C7B-4FEA-43D5-A93A-E5B8CB4884B4Q47738890-6626FECC-3F44-4E78-B246-F5670DAFF373Q47958974-BF3F2C49-A3B7-4ECD-851B-B33E9741F695Q48309590-513CBF51-A370-4A56-8D77-4A06A3301DBAQ48545881-C97911FB-8256-4D0D-8F85-6F57422250EFQ48662935-FA9E5BC1-D69E-46B6-8813-8F12E14FEE9AQ51041297-59D19AAB-175D-4A04-B451-9ED6939A6CBBQ51636097-29040CF2-7DD7-4784-8A9C-DE409D90A31EQ55411816-0AC62BF2-5718-450F-B73B-A7D97B5DD37EQ58780721-C0CB8CE7-7B7A-483F-B954-35ED3D86D4E5
P2860
Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Complications associated with ...... ith leptomeningeal metastases.
@en
Complications associated with ...... ith leptomeningeal metastases.
@nl
type
label
Complications associated with ...... ith leptomeningeal metastases.
@en
Complications associated with ...... ith leptomeningeal metastases.
@nl
prefLabel
Complications associated with ...... ith leptomeningeal metastases.
@en
Complications associated with ...... ith leptomeningeal metastases.
@nl
P2093
P1476
Complications associated with ...... ith leptomeningeal metastases.
@en
P2093
Chamberlain MC
Kormanik PA
P304
P356
10.3171/JNS.1997.87.5.0694
P407
P577
1997-11-01T00:00:00Z